Proefschriften

• Tumorcellen opsporen en behandelen tijdens operatie prostaatkanker
• Eiwit op tumorcellen opent deuren voor betere therapie en diagnostiek prostaatkanker
• Palliative Systemic Therapy for Salivary Gland Cancer

Klinische studies

Overzicht PSMA klinische studies

Nederlandse publicaties

• The New Editorial on EANM Focus 5 – consensus on molecular imaging and theranostics in prostate cancer proofs the multidisciplinarity character and the progress booked in this field. A nice celebration of a great event in February 2023, Seville, Spain.
• Appropriate Use Criteria for Prostate-Specific Membrane Antigen (PSMA) PET Imaging
• SNMMI AUC Factsheet for Prostate-Specific Membrane Antigen Imaging

Buitenlandse publicaties

• European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer
• [ 18F]DCFPyL PET/CT versus [ 18F]fuoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross‑over, comparative study
• AlphaBet: Combination of Radium-223 and [177Lu]Lu-PSMA-I&T in men with metastatic castration-resistant prostate cancer (clinical trial protocol)
• Nederlandse (wetenschappelijke) samenvatting van de VISION studie (internationale registratie studie van ¹⁷⁷Lu-PSMA) – Titel: Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
• Nederlandse (wetenschappelijke) samenvatting van de TheraP studie (studie die ¹⁷⁷Lu-PSMA vergeleek met cabazitaxel) – Titel: ¹⁷⁷Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
• Nederlandse (wetenschappelijke) samenvatting met de overlevingsdata van de TheraP studie (studie die 177Lu-PSMA vergeleek met cabazitaxel) – Titel: TheraP: 177Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel—Overall survival after median follow-up of 3 years (ANZUP 1603)
• Nederlandse (wetenschappelijke) samenvatting van de ProPSMA studie (studie die de 68Ga-PSMA PET onderzocht in patiënten met een recente diagnose hoog-risico prostaatkanker) – Titel: Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

Diagnostic Imaging

Wenzel M, Hussein R, Graefen M, Tilki D, Tobias T, Würnschimmel C. Long-term validation on the impact of PSMA-PET on metastasis-free survival in a large salvage radiotherapy cohort. Presented at 36th Annual EAU Congress (virtual). July 8-12, 2021. P1175.

Wenzel M, Hussein R, Graefen M, Tilki D, Tobias T, Würnschimmel C. Long-term validation on the impact of PSMA-PET on metastasis-free survival in a large salvage radiotherapy cohort. Presented at 36th Annual EAU Congress (virtual). July 8-12, 2021. P1175.